The global methenamine hippurate tablets market size was worth around USD 8.91 Billion in 2022 and is predicted to grow to around USD 14.74 Billion by 2030 with a compound annual growth rate (CAGR) of roughly 6.51% between 2023 and 2030.
???? Click Here to access The Full market Report : https://www.zionmarketresearch.com/report/methenamine-hippurate-tablets-market
➤ The market is expected to experience growth due to the increasing prevalence of UTIs.
The global methenamine hippurate tablets market is expected to expand as a result of the growing prevalence of UTIs worldwide. Urinary tract infections are a prevalent health issue that impacts millions of individuals worldwide. Escherichia coli (E. coli) is the most common bacterium that causes urinary tract infections (UTIs). It ascends to the patient’s bladder after entering the urethra. It is also capable of reaching the kidney in certain instances. The bacteria is recognized for its ability to infect various regions of the urinary tract, including the bladder, urethra, and kidneys. According to research, females are more susceptible to contracting the condition as a result of their anatomy, which includes a shortened urethra that facilitates the bacteria’s entry into the bladder.
➤ The bacteria’s ongoing evolution is limiting the market’s expansion.
The emergence of antibiotic-resistant bacteria is one of the primary factors that is expected to impede the growth of the global methenamine hippurate tablets market. The associated microorganisms have evolved to become resistant to the medication’s effects as a result of misuse or overuse of the medication. This is a significant concern in the medical community, as the effectiveness of tablets is now restricted by this evolution. Additionally, the industry’s development has been significantly impeded by the general public’s lack of awareness regarding urinary tract infections (UTIs) and precautionary or preventative measures.
➤ The increasing demand for preventive care is expected to generate growth opportunities.
The global industry may experience increased revenue during the forecast period as the world becomes more aware of the importance and advantages of preventive care, particularly in the wake of Covid-19. Preventive care is indispensable because it can help individuals sustain a healthy lifestyle and avert the development of any severe conditions. People can prevent the expenditure of expensive medical procedures and treatments in the future by taking the necessary precautions to maintain good health. For instance, one method of preventing urinary tract infections (UTIs) is to consume an abundance of water or to take medications such as methenamine hippurate tablets under the supervision of a physician.
➤ Insufficient availability in developing countries to impede market expansion
The tablets may not be easily accessible in developing nations or regions that are presently experiencing a variety of social, political, and economic factors. The global methenamine hippurate tablets industry size may be challenged by factors such as the absence of specialists, limited healthcare infrastructure, and other regulatory issues. Additionally, the industry’s challenging situations necessitate consideration of the growing prevalence of alternative techniques for the prevention or treatment of UTIs.
???? Get more info : https://www.zionmarketresearch.com/buynow/su/methenamine-hippurate-tablets-market
The Global Methenamine Hippurate Tablets Market is segmented based on product, application and region
Global Methenamine Hippurate Tablets Market: Product Segment Analysis
● 6 Tablets/ Bottle
● 20 Tablets/Bottle
Global Methenamine Hippurate Tablets Market: Application Segment Analysis
● Healthcare-associated UTIs
● Uncomplicated UTIs
Click on This Below Link to see Similar Reports :
https://www.linkedin.com/pulse/electric-lunch-box-market-size-industry-trends-nkhjf/
https://www.linkedin.com/pulse/global-methenamine-hippurate-tablets-qmf4f/
https://www.linkedin.com/pulse/olefins-market-size-share-industry-forecast-oabxf/
https://www.linkedin.com/pulse/global-plastic-crates-market-size-industry-trends-dtruf/
https://www.linkedin.com/pulse/hand-blender-market-size-share-trends-hq1df/
https://www.linkedin.com/pulse/home-bedding-market-size-industry-trends-historical-uhyyf/
https://www.linkedin.com/pulse/die-cut-lids-market-size-industry-trends-historical-yyznf/
https://www.linkedin.com/pulse/global-bee-venom-extract-market-size-p9juf/
https://www.linkedin.com/pulse/lignin-waste-market-size-share-trends-industry-qulgf/
The global Methenamine Hippurate Tablets market profiles key players such as:
● Almirall
● S.A.
● Mylan N.V.
● Merck & Co. Inc.
● Cadila Healthcare Ltd.
● Pfizer Inc.
● Dr. Reddy’s Laboratories Ltd.
● Teva Pharmaceutical Industries Ltd.
● Sun Pharmaceutical Industries Ltd.
● West-Ward Pharmaceuticals Corp.
● Abbott Laboratories
● Glenmark Pharmaceuticals Ltd.
● Bausch Health Companies Inc.
● Procter & Gamble Co.
● Jubilant Life Sciences Ltd.
● Lupin Pharmaceuticals Inc
???? Recent Developments:
• In March 2022, a study published in the British Medical Journal suggested that methenamine hippurate tablets have the same effect as antibiotics in treating urinary tract infections (UTIs), according to the findings of a UK-based research firm. This discovery is of paramount importance to the Indian healthcare sector, as low-dose antibiotics are presently permissible as a preventive treatment for urinary tract infections (UTIs) under the country’s medical guidelines.
• In November 2022, GSK, a prominent pharmaceutical company, disclosed that it had created a novel antibiotic that is highly effective in treating urinary tract infections (UTIs). This discovery is the first antibiotic to be developed in the past two decades, and the company states that it is highly effective. Management at GSK has already discontinued additional product testing due to their confidence in the antibiotic’s effectiveness. In the near future, they will submit data to the US Food and Drug Administration for the approval process.
➤ North America is expected to exhibit the greatest compound annual growth rate (CAGR).
North America is anticipated to experience the most significant development in the global methenamine hippurate tablets market, as a result of the increasing incidence of urinary tract infections. Moreover, the regional growth is bolstered by a greater degree of public awareness regarding the various preventive and treatment options that are available to address the condition. The revenue in North America is contingent upon the robust medical infrastructure of the United States and Canada.
???? Get Customization Report : https://www.zionmarketresearch.com/custom/7141
About Us :
Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database.
Contact Us:
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714 USA/Canada Toll-Free No.1-855-465-4651
Email: [email protected]
Website: https://www.zionmarketresearch.com
Be First to Comment